PENGEMBANGAN TRANSDERMAL DRUG DELIVERY SYSTEM (TDDS) PATCH METHYLDOPA SEBAGAI ANTIHIPERTENSI PADA KEHAMILAN
DOI:
https://doi.org/10.36387/jiis.v8i3.1647Keywords:
Transdermal, Patch, Methyldopa, HypertensionAbstract
Hypertension in pregnancy including chronic hypertension with or without pre-eclampsia, gestational hypertension increases maternal and infant mortality significantly. The treatment for hypertension in pregnancy is the administration of methyldopa. Methyldopa transdermal patch is made by mixing the polymer first and then adding the active substance, namely methyldopa drug. It is intended that the polymer becomes an outer layer that controls the release of the drug. The resulting transdermal patch formulation was then evaluated, including organoleptic test, pH test, weight uniformity test, patch thickness test, folding resistance test, moisture test and penetration test using Franz diffusion cell. SPSS statistical data analysis. The penetration rate results showed F1 with 832.16 µg/cm2, F4 with 767.95 µg/cm2, F2 with 2819 µg/cm2 and F3 with 275.38 µg/cm2 all formulas have met the requirements. Based on the results of physical characteristics evaluation research, all formulas have met the requirements. The results of the in vitro evaluation of the methyldopa patch transdermal penetration test found that the difference in concentration in each formula had no significant effect on the penetration test. Based on physical evaluation parameters and in vitro penetration tests, the most optimal formula is F4 with the ratio of HPMC and ethyl cellulose (300:100) seen by fulfilling all physical characteristic evaluation tests and having a constant percent of cumulative amount to rise.
References
Alatas, H. 2019 ‘Hipertensi pada Kehamilan’, Herb-Medicine Journal, 2(2), p. 27. Available at: https://doi.org/10.30595/hmj.v2i2.4169.
Alvionita, R., Samidah, I. and Murwati, M. 2022 ‘Faktor-Faktor Yang Berhubungan Dengan Kejadian Hipertensi Kehamilan Di RSUD Curup Tahun 2022’, Journal of Nursing and Public Health Vol. 10 No. 2 Oktober 2022, 10(2), pp. 198–209.
Amalia, R. 2021 ‘Evaluasi Sifat Fisik Dan Uji Penetrasi Pada Formulasi Sediaan Transdermal Patch Dimenhidrinat Dengan Variasi Polimer HPMC Dan Etil Selulosa’. Banjarmasin.
Depkes RI 1995 Farmakope Indonesia edisi IV, Departemen Kesehatan Republik Indonesia.
Hendarti, H.F. 2016 Evaluasi Ketepatan Obat dan Dosis Obat Antihipertensi pada Pasien Hipertensi Rawat Jalan di Puskesmas Ciputat Januari-Maret 2015., Universitas Islam Negeri Syarif Hidayatullah Jakarta.
Ilyas, L.I. 2014 ‘Studi Karakteristik Formula Patch Bukal Mukoadesif Kaptopril’.
Novia 2021 ‘Pengaruh Kombinasi Polimer Polivinil Pirolidon Dan Etil Selulosa Terhadap Karakteristik Dan Uji Penetrasi Formulasi Transdermal Patch Ekstrak Bawang Dayak (Eleutherine palmifolia (L)’. Banjarmasin.
Rifai, M. and Safitri, D. 2022 ‘Edukasi Penyakit Hipertensi Warga Dukuh Gebang Kabupaten Gunungkidul Jurnal BUDIMAS ( ISSN : 2715-8926 )’, Jurnal BUDIMAS (ISSN:2715-8926) vol. 04, 04(02), pp. 1–6.
Suciati, R. and Wiyoko, P.F. 2022 ‘Hubungan Paritas dengan kejadian Hipertensi pada Kehamilan’, 4(1), pp. 9–15.
Syahrana, N.A. et al. 2021 ‘Pengaruh Perbandingan Konsentrasi Polimer terhadap Karakteristik dan Laju Pelepasan Patch Transdermal Nifedipin’, Jurnal Sains dan Kesehatan, 3(1), p. 35.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jurnal Ilmiah Ibnu Sina
![Creative Commons License](http://i.creativecommons.org/l/by-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.